Updates matching "Cancer Research Funding"

The House Appropriations Committee will vote today to approve its FY 2023 spending bill including a $2.5 billion funding increase for the National Institutes of Health (NIH), a $466 million funding boost for the National Cancer Institute (NCI) and $2.75 billion for the Advanced Research Projects Agency on Health (ARPA-H).

Dr. Karen E. Knudsen, the Chief Executive Officer of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN), will testify before the House Appropriations Subcommittee on Labor, Health, and Human Services and Education, and related agencies today in support of increased federal funding for the National Institutes of Health (NIH), National Cancer Institute (NCI) and the Centers for the Disease Control and Prevention (CDC).

Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.

National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.

WASHINGTON, D.C.— Monday the Biden administration released its FY 2023 budget, which includes $5 billion for the forthcoming creation of the Advanced Research Project on Health (ARPA-H) but reduces funding by nearly $200 million for the National Cancer Institute (NCI); a scenario which may threaten to undermine the president’s

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.

The American Cancer Society Cancer Action Network (ACS CAN) has been provided nearly one million dollars in support from Amgen for a pilot program to test a trial eligibility screening intervention intended to increase and diversify patient enrollment in cancer clinical trials.

head of the president’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is offering numerous policy suggestions for ways in which the administration and Congress can achieve the president’s ambitious Cancer Moonshot goal.

Nearly 100 cancer organizations representing patients, providers and researchers sent a letter to the president and congressional leadership in support of funding the Cancer Moonshot initiative